ArticleAnalytical and bioanalytical chemistry2025
A multi-detector analytical approach for characterizing complex botanical extracts: a case study on ashwagandha.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Vision to Reality: Five Years of the Botanical Safety Consortium.Pharmaceutical biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A comprehensive analytical characterization of botanical extracts can be difficult due to their complexity, dynamic range, and limited availability of constituent standards. By using ashwagandha root extract as a case study, this work showcases how to characterize a botanical extract utilizing an analytical system with multiple detectors to support the development of toxicological tools for evaluating botanicals. The platform incorporated ultra-high-performance liquid chromatography (UHPLC) coupled with photodiode array (PDA) detection, charged aerosol detection (CAD), and high-resolution mass spectrometry (HRMS) detection to generate a detailed chemical profile. This multi-detector platform enabled both semi-quantification and the identification of the majority of constituents, ensuring accurate chemical analysis while compensating for potential detector biases. The approach provided a thorough fingerprint of the ashwagandha extract, enabling authentication of the material. The generation of a comprehensive fingerprint supports in silico modeling and bioassay-based toxicological evaluations of botanicals, particularly in the context of dietary supplement safety. This study demonstrated the utility of detailed chemical analysis supporting the authenticity of ashwagandha root extract and the advancement of tools needed for robust safety assessments of botanical products by providing the semi-quantification and identification of over 60 constituents in ashwagandha extracts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.